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Continuous glucose monitoring (CGM) devices, with their 1-5min measurement interval, allow blood 
glucose concentration (BG) dynamics to be captured more frequently and less invasively than traditional 
BG measures. One cohort CGM could provide insight is athletes.  This study investigates what impact their 
heightened energy expenditure and dietary intake may have on their ability to achieve optimal BG.   
 
Methods: 
Ten sub-elite athletes (resting HR<60bpm, training>6hrs per week) were recruited. Two Ipro2 CGM 
devices (Medtronic Minimed, Northridge, CA) were inserted into the abdomen and remained in place for 
~6days.  Time in band was calculated as the percentage of CGM BG measurements with in the 4.0 - 
6.0mmol/L. Fasting glucose was calculated using CGM calibration BG measurements and postprandial 
glucose response was also calculated using the CGM values.  
 
Results:  
4/10 athletes studied spent more than 70% of the total monitoring time above 6.0mmol/L even with the 
2hour period after meals is excluded. Fasting blood glucose was also in the ADA defined pre-diabetes 
range for 3/10 athletes. Only one participant spent substantial time below 4.0mmol/L which was largely 
due to significantly lower energy intake compared to recommendations. 
 
Conclusions: 
Contrary to expectations high BG appears to be more of a concern for athletes then low BG even in those 
with the highest energy expenditure and consuming below the recommended carbohydrate intake. This 
study warrants further investigation on the recommended diets and the BG of athletes to better 




The World Health Organisation (WHO) defines normal glycaemia as fasting glucose less than 6.1mmol/L 
and recommends that glucose be <7.8mmol/L 2hours after a 75g oral glucose tolerance test (OGTT)  test 
[1]. The American Diabetes Association (ADA) considers those with a fasting glucose of 5.6 – 6.9mmol/L 
and blood glucose (BG) > 7.8 -11.0mmol/L after an OGTT at increased risk of diabetes [2]. However, as the 
WHO guidelines explain, there is no definitive cut off for “normoglycaemia” [1].  
Continuous glucose monitoring (CGM) devices, with their 1-5 minute measurement interval, allow blood 
glucose concentration (BG) dynamics to be captured far more frequently and less invasively than 
traditional BG measures. CGM devices typically consist of a small pager-like monitoring device that 
receives a signal from a sensor inserted into the subcutaneous layer. The sensor creates a signal using the 
glucose oxidase reaction and produces a current proportional to the glucose concentration in the 
surrounding interstitial fluid. The signal is converted into a BG value by using calibration BG 
measurements, which are entered into the monitor by the user every ~6-8hrs. 
These devices are primarily designed for use in individuals with  type 1 and type 2 diabetes  to aid BG 
regulation and are well studied in this cohort [3, 4]. However, because of the increased measurement 
frequency and reduced invasiveness they have recently been applied to other cohorts, such as intensive 
care patients and neonates, with varying success [5-12].  Another, perhaps overlooked, cohort where the 
more intensive metabolic monitoring provided by CGM may be beneficial is athletes.  
Athletes are traditionally encouraged to consume a diet rich in carbohydrates to ensure adequate 
glycogen stores and improve performance [13-15]. Physical training is known to improve insulin 
sensitivity, both immediately post exercise and through multiple long term adaptations in glucose 
transport and metabolism [16]. However in contrast, strenuous exercise is known to increase circulating 
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concentrations of catecholamines, such as adrenalin and noradrenaline, to near pathological levels [17, 
18] resulting in hyperglycaemia and hyperinsulinemia post intense exercise [17, 19, 20].   
This study aims to use the CGM blood glucose profiles and dietary habits of sub-elite athletes to 
investigate if this cohort is achieving optimal blood glucose levels during normal free living and training. 
The CGM data provides a unique insight in to the day to day blood glucose levels of Athletes that could 
not be achieved without the application of this technology.  In particular, it asks what impact their 
increased insulin sensitivity, heightened energy expenditure and increased exposure to stress hormones 
have on their blood glucose levels.   
Methods  
Ten fit, healthy sub-elite athletes (resting HR <60bpm) were recruited under informed written consent for 
a study into optimal athlete nutrition (henceforth referred to as athletes). Table 1 summarizes the cohort 
demographics. All subjects regularly trained > 6 hours per week in a range of endurance based sports, 
predominantly running and cycling. Participants were free living during the monitoring period and did not 
have tailored nutritional programs from this study or an existing coach. The research procedures and use 
of data were approved by the University of Canterbury Human Ethics Committee. 
Table 1. Cohort demographics of the participants. Data are presented as median [interquartile range] where 
appropriate 
Number 10 
Age (yr) 28 [23 37] 
Gender (M/F) 7/3 
BMI (kg/m2) 22 [21 24] 
Resting HR (bpm) 55 [53 56] 
VO2max (mL/kg/min) 46 [39 59] 
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Two Ipro2 and one Guardian Real-time CGM devices (Medtronic Minimed, Northridge, CA, USA) were 
inserted into the abdomen of each athlete ~24 hours prior to the first ‘fasted exercise test’. The CGM 
device remained in each subject for 4 - 6 days.  For all athletes, the Ipro CGM devices were both inserted 
in to the left side of the abdomen and the Guardian in the right side. These devices are referred to as 
sensor 1 (SG1), the lower left abdomen sensor, sensor 2 (SG2), the upper left abdomen sensor, and the 
real-time sensor in the right abdomen sensor (SGrealtime).  Figure 1 shows these locations which are 
typical for these devices. The Guardian Real-time data was not used in this analysis. Two Ipro2 sensors 
were worn to provide redundancy in case of sensor failure, which is not immediately apparent with these 














During the ~6 days of CGM per athlete:  
• Blood glucose was measured 4 times per day prior to meals, thus including morning fasting, and 
sleeping. These measurements were used to calibrate the device (calibration BG)   
• All meals and snacks were recorded (self-reporting) and carbohydrate, sugar, fibre, protein and 
fat intake was calculated  
• Any exercise was also recorded (self-reporting) and energy expenditure estimated  
• A fasted exercise test was carried out on Day 2, as shown in Figure 2. 
Calibration BG measurements were taken using capillary finger stick measurements and the Abbott 
Optimum Xceed (Abbott Diabetes Care, Alameda, CA) glucometer. The Abbott device has reported error 
of 5-10% [9, 21-23].  A body composition analysis was undertaken by 8 of the 10 participants prior to the 
fasting test using a Body composition Analyser (InBody230, InBody Bldg, Seoul, Korea).  
 
 






Sensor glucose (SG) data from measured CGM traces of the two Ipro2 devices was analysed. These devices 
have shown to have very good accuracy and sensor agreement in active individuals [8, 24]. The two signals 
were averaged at each time step for the time period they were worn to provide a single, reliable trace of 
BG. For Ath04, Ath09, and Ath10 only one CGM trace was available due to sensor failure.  
For each athlete, the cumulative distribution (CDF) of BG data was analysed for the entire 5-6 days of 
monitoring, and re-analysed with the 2 hour period following any meal or snack removed. Time in band 
was calculated as the percentage of SG with in the 4.0 - 6.0mmol/L during the two different monitoring 
periods. Although a consensus has yet to be reached on what normal glucose levels, intensive insulin 
therapy studies show achieving higher time in this band results in improved patient outcomes [25-27] and 
it lies below typical thresholds for diabetes diagnosis [1, 2]. Many studies have also demonstrated the 
linearly increasing risks associated with hyperglycaemia, regardless of diabetes status, with lower limits 
between 4.0 – 6.0mmol/L [1, 28-33].  
The average carbohydrate, sugar, and fibre intake (g/day) while using CGM were calculated.  First, daily 
caloric intake was calculated using basal metabolic rate (BMR) as estimated by the body composition 
analysis. For 2/10 athletes, Ath02 and Ath03, body composition analysis results were not available. 
Therefore, BMR was estimated using the standard equations [34] that take in to account height, weight 
and age. This BMR was then multiplied by an activity factor [35] considering the amount of exercise 
undertaken by the athlete during the monitoring period. This process and relating caloric requirements 
are shown in Table 2.  
US dietary guidelines [36] recommend 45-65% of total calorie intake be from carbohydrates and the 
recommended amount of added sugars is also related to calorie level in these guidelines. Added sugar 
content of food consumed during the monitoring period was calculated using the United States 
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Department of Agriculture (USDA) database [37]. If the added sugar content was not available from the 
database it was assumed to be zero, providing an overall conservative estimate. 
Table 2: The process of calculating the caloric requirements based on BMR and activity level and the average 
calorie intake achieved by each subject. * Values were calculated using standard equations rather than a 
body composition analysis.  
Subject BMR 
(kcal) 







Intake per Day 
(kcal/d) 
ATH01 1342 84 1.9 2550 2147 
ATH02 1868* 41 1.7 3176 3864 
ATH03 1927* 68 1.9 3661 1877 
ATH04 1770 93 2.1 3717 3555 
ATH05 1680 158 2.3 3864 2568 
ATH06 1694 28 1.5 2541 2654 
ATH07 1780 20 1.5 2670 2838 
ATH08 1895 24 1.5 2843 4144 
ATH09 1379 102 2.1 2896 2726 
ATH10 1400 42 1.7 2380 2363 
 
Fasting blood glucose (FBG) was calculated as the median value of the calibration measurements taken 
prior to breakfast over the 5-6days of CGM monitoring. Fasting plasma insulin (FPI) was determined by 
the first plasma insulin measurement taken prior to starting the fasted exercise test on Day 2 (Figure 2). 
Fasting insulin secretion (FIS) was calculated from the initial C-peptide measurement taken prior to 
starting the fasted exercise test using the method of Van Cauter et al. [38] assuming steady-state, as 
subjects were fasted.  
Postprandial glucose response (PPGR) was calculated as the incremental area under the BG curve after a 
meal [39]. Only the area above the starting glucose value was considered. PPGR was only considered for 
meals that had greater than 30g of carbohydrate, and where there was no meal of greater than 15g 
carbohydrate in the 2 hours prior to or after this meal. If meals were consumed within 15 minutes then 
carbohydrate content was combined and the 2 hour area under the curve considered from the start of 
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the second meal. Postprandial glucose (PPG) was the glucose value recorded two hours after a meal under 
the same conditions as above.  
 
Results  
Individual SG profiles are shown in Figure 3 and Figure 4. These profile highlight the very unique response 
of each individual to exercise and carbohydrates. Ath02 and Ath04 both show very little variation in SG 
but Ath02 SG is centred on a higher glucose value resulting in more time out of the 4.0 – 6.0mmol/L. Other 
subjects such as Ath03 and Ath09 show a large variation in SG, once again centred on different glucose 
levels resulting in Ath03 displaying the most hypoglycaemia and Ath09 displaying the most 
hyperglycaemia. Also individual plots for each SG profile can be found in the supplementary material 
accompanying this article. These plots show both SG profiles and the resulting averaged SG.  
In Figure 5 it is further evident participants spend a significant amount of time outside the normoglycemic 
4.0 - 6.0mmol/L range. Once meals are removed, in the bottom plot, there is a distinct separation between 
4/10 of the subjects (Ath05, 07, 08, 09) who have less than 30% time in the 4.0 - 6.0mmol/L. In contrast, 
the remaining 6/10 participants achieve over 85% time in the desired 4.0 - 6.0mmol/L range, which is clear 
when comparing the distributions.  
All but 4 participants consumed on average an amount of carbohydrate that was between 45 – 65% of 
their recommended daily calorie intake. Ath03, Ath05 and Ath09 did not reach the minimum 
recommended amount of carbohydrate. Ath08 consumed more than 65% of their recommended intake 
as carbohydrate. All participants achieved their recommended fibre intake of >25g. Some participants, 
such as Ath07 and Ath08, have a very low fibre to sugar ratio and nearly double the recommended intake 
of added sugars (Figure 6). Ath03 consumed on average ~150g of carbohydrate less than the lower 
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recommended limit, 1770 kcal less than required (Table 2) and was the only participant to demonstrate a 
significant amount time below 4.0mmol/L.  
Table 3 shows Ath05, Ath07 and Ath09 have elevated fasting glucose within the pre-diabetes range 5.6 - 
6.9 mmol/L suggested by the ADA. However, none of the subjects met the pre-diabetes criteria of PPG > 
7.8mmol/L. Although this criteria is  based on the BG 2 hours after a 75g glucose tolerance test rather 
than after an uncontrolled meal.  The mean PPGR ranges from 0.2 – 2.0 mmol/L.hr displaying a wide range 
intra and inter of carbohydrate sensitivity. High PPGR did not necessarily correlate with time out side of 




Figure 3: CGM profiles for the first 5 subjects. The 2 hour postprandial meal response is highlighted in red 




Figure 4: CGM profiles for the last 5 subjects. The 2 hour postprandial meal response is highlighted in red and 




Figure 5: Cumulative distribution plots of measured CGM values. The Top plot is the CDF of the entire 
averaged CGM signal. The bottom plot is the CGM signal with 2 hours from the beginning of each meal and 




Figure 6: Bar plot showing the average intake per day of carbohydrate, sugar, fibre, and the recommended 
daily intake of carbohydrate, upper (65% of calorie intake) and lower (45% of calorie intake)  











































Table 3: Summary table of measured physical and metabolic variables, where PBF = Percent Body Fat, FFM = Fat Free Mass, FBG = Fasting Blood 
Glucose, FPI = Fasting Plasma Insulin, FIS = Fasting Insulin Secretion, TIB –MR = Time in Band, with meals removed, Maxppg = the maximum blood 
glucose value reached after a meal, PPG = the blood glucose value 2 hours after a meal. Body composition analysis results were not available for Ath02 
and Ath03 hence PBF and FFM values are missing.   
 























ATH01 F 23 21.6 25.3 45 5.2 9.0 1319 86.6 1.1 6.1 84 39 
ATH02 M 23 21.9 - - 5.1 6.3 913 90.7 0.5 6.0 41 60 
ATH03 M 50 26.4 - - 4.7 11.8 1878 76.1 1.9 6.0 68 39 
ATH04 M 23 20.4 5.1 64.8 4.6 6.5 832 99.2 0.5 5.5 93 67 
ATH05 M 28 24.2 14.1 60.6 6.0 6.3 820 30.7 0.9 6.8 158 59 
ATH06 M 36 22.4 15.5 63.3 4.4 8.3 1844 94.3 1.2 5.9 28 59 
ATH07 M 37 26.0 19.7 65.3 6.7 10.5 1553 23.9 1.1 7.1 20 42 
ATH08 M 22 24.5 13.2 70.6 5.5 11.0 1550 31.7 0.2 5.5 24 37 
ATH09 F 37 21.1 17.8 46.7 6.0 6.0 936 9.7 2.0 7.4 102 47 




Physical training is known to improve insulin sensitivity, both immediately post exercise (up to 2 hrs) and 
through multiple adaptations in glucose transport and metabolism [16]. Therefore, it could be expected 
high BG would not be frequently seen in athletes and low BG would be of greater concern due to increased 
energy expenditure. However, this hypothesis does not appear to be the case in the data we have 
collected.  
In particular, 4/10 subjects spent more than ~70% of the total monitoring period with SG > 6.0mmol/L 
even with the two hour period after meals removed.  Only one athlete experienced a significant time 
below 4.0mmol/L and this behaviour appears largely due to a considerably decreased calorie intake 
compared to recommended guidelines.  
Ath09 and Ath05 undertook the most exercise during the monitoring period, averaging 102 and 
158min/day respectively.  This high training load could have contributed to the low time in the 4.0 – 
6.0mmol/L band, as exercise is known to increase blood glucose and induce hyperglycaemia and 
hyperinsulinemia as a result of this catecholamine response [17, 19, 20].  Both subjects have the lowest 
fasting plasma insulin and insulin secretion recorded suggesting efficient glucose uptake. In addition, both 
achieved VO2max values that put them in the excellent category based on their gender and age.  
Ath07 and Ath08 carried out the least amount of exercise during the monitoring period only averaging 20 
and 24min/day of exercise, while over consuming added sugars [1] and Ath08 over consuming on the 
recommended carbohydrate intake.  Lowering physical activity is known to impact the glycaemic control 
of healthy individuals and the increased insulin sensitivity witnessed due to training wanes with 5 days of 
detraining [16, 40-42]. The large amount of time spent out of band by Ath07 and Ath08 is likely to be 
attributed to these diet and lifestyle choices. This conclusion is supported by Ath07 and Ath08 showing 
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the highest fasting plasma insulin levels and fasting insulin secretion and only achieving average or above 
average category VO2max levels based on gender and age.  
An individual’s tolerance of carbohydrate is highly variable and is related to a number of factors including 
age and genetics [43, 44]. A differing ability to tolerate carbohydrates in this cohort is demonstrated with 
the wide range of cohort values of mean PPGR and mean PPG, 0.2 – 2.0mmol/L.h and 5.5 – 7.4mmol/L 
respectively. Also PPGR and PPG do not necessarily correlate with time in band or FBG. A subject can 
achieve good overall control or even experience low BG, such as Ath03, but still demonstrate a high mean 
PPGR indicating a high sensitivity to carbohydrates. A subject like ATH09 also appears to have a very high 
sensitivity to carbohydrates achieving high PPGR and low time in band while under consuming on the 
recommended carbohydrate intake. However, a subject like Ath04 displays a very high tolerance of 
carbohydrates, achieving the greatest time in band and very low PPGR, while still over consuming added-
sugars. It is interesting to note that normalising results by grams of carbohydrate consumed did not 
change the trends seen.   
Athletes are traditionally encouraged to consume high carbohydrate diets to replenish muscle glycogen 
stores and improve performance, with a particular focus on post exercise carbohydrate consumption [13-
15].  However, this advice may be negatively impacting the blood sugar levels of athletes predisposed to 
have a low tolerance of carbohydrates. In addition it is unlikely that low BG in day to day life is a real 
concern for athletes, unless they are significantly under consuming calories. Hence, the potential for a 
more personalised nutrition plan aided by CGM to optimise the BG levels during different phases of 
athletes training is highlighted by these results.   
This study warrants further investigation on the recommend diets and the blood glucose levels of athletes, 
in particular those in the sub-elite category studied here. Sub-elite athletes are unlikely to have the same 
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nutritional and dietary support from trained professionals as elite athletes. Hence, their nutritional intakes 
are more perhaps likely to be sub-optimal, as demonstrated in this study. 
 
Limitations 
This study is limited by the small cohort size. However, this initial pilot investigation has highlighted some 
interesting points where there is potential to optimise an athlete’s diet. Hence, it has raised questions 
where further studies are thus justified. 
 A second limitation is that activity was only monitored by self-reporting in future studies it would be much 
better to use a specific activity monitoring device to capture energy expenditure more accurately. Equally, 
activity could be directly controlled in a more homogenous cohort, in a more strictly controlled study than 
this pilot investigation.  
 
Conclusion  
Physical training is known to significantly increase insulin sensitivity and improve PPG and PPGR. 
Therefore, it could be expected sustained high BG during free living would not be frequently seen in 
athletes and low BG would be of greater concern due to increased energy expenditure. However, this 
hypothesis does not appear to be the case in the data we have collected. When the sensor glucose profiles 
of 10 trained, sub-elite athletes were analysed over a 6 day monitoring period 4/10 athletes studied spent 
more than 70% of the total monitoring time above 6mmol/L even with the 2hour period after meals 
removed. FBG was also in the range of pre-diabetes for 3/10 athletes as defined by the ADA. Only one 
participant spent substantial time below 4mmol/L and this was largely due to a significantly lower overall 
calorie intake compared to recommendations. A differing ability to tolerate carbohydrates in this cohort 
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is demonstrated with the wide range of cohort values of mean PPGR and mean PPG, 0.2 – 2.0mmol/L.h 
and 5.5 – 7.4mmol/L respectively. Therefore, a diet rich in carbohydrates may not be beneficial in some 
athletes, especially as low BG is unlikely to be of concern to an athlete consuming adequate calorie intake. 
This study provides a unique insight in to the day to day glucose levels of athletes that could only be 
achieved through the use of CGM devices highlighting the need for further investigation on the 
recommend diets of athletes to better determine the causes and impact of the hyperglycaemia seen on 
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 Table 4. Cohort demographics of the participants. Data are presented as median [interquartile range] where 
appropriate 
Number 10 
Age (yr) 28 [23 37] 
Gender (M/F) 7/3 
BMI (kg/m2) 22 [21 24] 
Resting HR (bpm) 55 [53 56] 
VO2max (mL/kg/min) 46 [39 59] 
 
 
Table 5: The process of calculating the caloric requirements based on BMR and activity level and the average 
calorie intake achieved by each subject. * Values were calculated using standard equations rather than a 
body composition analysis.  
Subject BMR 
(kcal) 







Intake per Day 
(kcal/d) 
ATH01 1342 84 1.9 2550 2147 
ATH02 1868* 41 1.7 3176 3864 
ATH03 1927* 68 1.9 3661 1877 
ATH04 1770 93 2.1 3717 3555 
ATH05 1680 158 2.3 3864 2568 
ATH06 1694 28 1.5 2541 2654 
ATH07 1780 20 1.5 2670 2838 
ATH08 1895 24 1.5 2843 4144 
ATH09 1379 102 2.1 2896 2726 





Table 6: Summary table of measured physical and metabolic variables, where PBF = Percent Body Fat, FFM = FatFree Mass, FBG = Fasting Blood 
Glucose, FPI = Fasting Plasma Insulin, FIS = Fasting Insulin Secretion, TIB –MR = Time in Band, with meals removed, Maxppg = the maximum blood 
glucose value reached after a meal, PPG = the blood glucose value 2 hours after a meal. Body composition analysis results were not available for Ath02 
and Ath03 hence PBF and FFM values are missing.    























ATH01 F 23 21.6 25.3 45 5.2 9.0 1319 86.6 1.1 6.1 84 39 
ATH02 M 23 21.9   5.1 6.3 913 90.7 0.5 6.0 41 60 
ATH03 M 50 26.4   4.7 11.8 1878 76.1 1.9 6.0 68 39 
ATH04 M 23 20.4 5.1 64.8 4.6 6.5 832 99.2 0.5 5.5 93 67 
ATH05 M 28 24.2 14.1 60.6 6.0 6.3 820 30.7 0.9 6.8 158 59 
ATH06 M 36 22.4 15.5 63.3 4.4 8.3 1844 94.3 1.2 5.9 28 59 
ATH07 M 37 26.0 19.7 65.3 6.7 10.5 1553 23.9 1.1 7.1 20 42 
ATH08 M 22 24.5 13.2 70.6 5.5 11.0 1550 31.7 0.2 5.5 24 37 
ATH09 F 37 21.1 17.8 46.7 6.0 6.0 936 9.7 2.0 7.4 102 47 

















Figure 3: CGM profiles for the first 5 subjects. The 2 hour postprandial meal response is highlighted in red 




Figure 4: CGM profiles for the last 5 subjects. The 2 hour postprandial meal response is highlighted in red and 





Figure 5: Cumulative distribution plots of measured CGM values. The Top plot is the CDF of the entire 
averaged CGM signal. The bottom plot is the CGM signal with 2 hour from the beginning of each meal and 




Figure 6: Bar plot showing the average intake per day of carbohydrate, sugar, fibre, and the recommended 
daily intake of carbohydrate, upper (65% of calorie intake) and lower (45% of calorie intake)  
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